Scholarly article on 4-oxo-4-(2-oxo-cyclohexyl)-butyric acid ethyl ester 100521-07-1 from Journal of the American Chemical Society p. 731,734

DOI: 10.1111/j.1745-6584.2002.tb02500.x

Source and publish data:

Journal of the American Chemical Society p. 731,734 (1957)

Update date:2022-08-04

Topics:

Authors:

Hauser Hauser

Linn Linn

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1111/j.1745-6584.2002.tb02500.x

Full text of DOI:10.1111/j.1745-6584.2002.tb02500.x

Products guided by the article

Product name:4-oxo-4-(2-oxo-cyclohexyl)-butyric acid ethyl ester

Cas No:100521-07-1

R&D Labs maybe for 100521-07-1

Jinan Yufeng Bioengineering Co., Ltd.

Contact:+86-531-83130545/83130528/83130525/83130505

Address:Rm415,Building2,No19,Huaneng Road,Jinan, Shandong, China
JinTan Pingsheng Chemical Co.,Ltd

Contact:+86-519-82828200

Address:NO.11Danfengxilu Road,Jintan City,Jiangsu,China
Aminodiscovery Co.,Ltd.

Contact:+86-535-8888888

Address:No.161 Haishi Rd.
Zhengzhou Yuanli Biological Technology Co., Ltd.

Contact:+86-371-67897870/67897895

Address:No. 38, Qingyang Street, Zhengzhou, Henan, China
zhenjiang runjing high purity chemical co ltd

Contact:+86-511-83361155

Address:No.8.haixi road,international chemical park

Relevant to this article

Scalable synthesis of the VEGF-R2 kinase inhibitor JNJ-17029259 using ultrasound-mediated addition of MeLi-CeCl₃ to a nitrile

Doi:10.1021/jo7021372
(2008)
Synthesis, antitubercular and anticancer activities of substituted furyl-quinazolin-3(4H)-ones

Doi:10.1002/ardp.200700096
(2007)
Total synthesis of the proposed structure of the anthrapyran metabolite δ-indomycinone

Doi:10.1002/chem.200700823
(2007)
Iron-mediated intermolecular N-group transfer chemistry with olefinic substrates

Doi:10.1039/c3sc52533c
(2014)
Synthesis of 4-unsubstituted 2H-1,2,3-benzothiadiazine 1,1-dioxides via ortho lithiation of protected benzaldehyde derivatives

Doi:10.1016/j.tet.2013.11.058
(2014)
Site-Specific Immuno-PET Tracer to Image PD-L1

Doi:10.1021/acs.molpharmaceut.9b00010
(2019)

Article Doi

DOI: 10.1111/j.1745-6584.2002.tb02500.x

Source and publish data: